Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that management will take part in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq World Headquarters in New York City on May 19, 2026. A live webcast and replay will be available on the company’s investor relations Events page.
Details
News Market Reaction – LXRX
On May 12, the day this news came out, LXRX closed 4.33% above the previous close. That session’s volume was 2.3x the stock’s average daily volume.
Data tracked by StockTitan Argus for the May 12 session.
Key Figures
- Conference date
- May 19, 2026
- Date of fireside chat at H.C. Wainwright BioConnect
- Conference edition
- 4th Annual
- H.C. Wainwright BioConnect Investor Conference
Historical Context
-
Q1 2026 results with higher revenue and multiple clinical program updates.
-
New $100M Hercules loan facility with initial $55M tranche to refinance debt.
-
Announcement of Q1 2026 results date and conference call logistics.
-
AAN presentations featuring Phase 2b and preclinical data for pilavapadin and spasticity.
-
ACC presentations on sotagliflozin including SCORED and SOTA-P-CARDIA analyses.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026.
The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit www.lexpharma.com.
For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.